Article first published online: 9 JAN 2012
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Special Issue: Biotech Methods and Advances
Volume 7, Issue 1, pages 9–13, January 2012
How to Cite
(2012), BTJ Editors. Biotechnology Journal, 7: 9–13. doi: 10.1002/biot.201290004
- Issue published online: 9 JAN 2012
- Article first published online: 9 JAN 2012
is Professor at the Department of Biotechnology of the University of Natural Resources and Life Sciences, Vienna, Austria, since 1997 and holds a visiting professorship at Bioprocessing Technology Institute in Singapore since 2006. Since 2001 he is Head of the research group working on downstream processing and the Christian Doppler Laboratory of Receptor Biotechnology. He also became a group leader at the Austrian Center of Industrial Biotechnology. His main research interest is in the field of recombinant protein, plasmid, virus and virus-like particle production, characterization of proteins and engineering principles of bioprocessing. He has more than 200 international publications and 15 patents in the field of biochemical engineering science.
Sang Yup Lee
is Distinguished Professor at the Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST). He is currently the Dean of College of Life Science and Bioengineering, Director of Center for Systems and Synthetic Biotechnology, Director of BioProcess Engineering Research Center, and Director of Bioinformatics Research Center. He has published 390 journal papers, 56 books/book chapters, and more than 540 patents either registered or applied. He has received numerous awards including National Order of Merit, Merck Metabolic Engineering Award from Merck, and Elmer Gaden Award from Biotechnology and Bioengineering. He is currently Fellow of AAAS, Fellow of American Academy of Microbiology, Fellow of Korean Academy of Science and Technology, Fellow of Society for Industrial Microbiology, Foreign Associate of National Academy of Engineering (USA), Chair of the Global Agenda Council on Emerging Technologies of World Economic Forum, and Co-Chair of the World Council on Industrial Biotechnology. Sang Yup is also dedicated to scientific advancement through his role as Editor-in-Chief of Biotechnology Journal, and Associate Editor and board member of numerous other journals. His research interests are systems biology and biotechnology, synthetic biology, industrial biotechnology, metabolic engineering, and nanobiotechnology.
joined Wiley in January 2008 as Assistant Editor for the European Journal of Immunology. Judy brought with her expertise in both biotechnology and immunology, having completed her bachelor's degree in Biotechnology (BTech, Hons) in New Zealand and PhD in Biomedical Engineering (Immunology) in Australia. Judy's postdoctoral training was at the NIH in the USA, where she studied tumour immunosurveillance in the murine model. Since joining Wiley, Judy has been promoted to Associate Editor in 2009. In January 2011, Judy took on the role of Managing Editor for Biotechnology Journal, also oversees Engineering in Life Sciences and BiotecVisions, and continues to be involved in the strategic development of the European Journal of Immunology.
graduated in Molecular Biotechnology at the University of Bielefeld, Germany in 2005. Prior to that, she also completed an MSc in Molecular Pharmacology at the University of Manchester (UK) in 2004, where she worked on the effects on mitochondrial lipids during apoptosis in zebrafish. For her PhD Uta studied at the German Cancer Research Center (DKFZ), in Heidelberg, Germany, studying liver tumor models in mice and the death receptor ligand TRAIL. The degree was awarded to her in 2008 from the University of Heidelberg. In 2009 she joined Wiley as Assistant Editor for Biotechnology Journal and Engineering in Life Sciences, and is also Editor for the magazine BiotecVisions.
received her bachelor's degree in Veterinarian Medicine in 2005, and completed her PhD in Microbiology from Shanghai Jiao Tong University in 2011. During this period, she studied and worked in Guelph Food Research Centre, Agriculture and Agri-Food Canada as a joint PhD student for nearly 2 years, where she studied the involvement of quorum sensing in intestinal cell damage induced by enterotoxigenic Escherichia coli. Jing joined Wiley in July 2011 as Editorial Assistant for Biotechnology Journal and is based in Wiley's Shanghai office, where she is also dedicated to providing support to authors in China.
is Professor of Molecular Biotechnology and Dean of Faculty at KTH, Stockholm, Sweden. The focus of her current research is the development of predictable and robust systems for protein purification and detection by protein design and various selection methodologies. Her key scientific achievements include characterization of the folding pathway of IGF-1, design and development of gene fusion systems for selective ion-exchange purification and improvements of the alkaline tolerance of protein A and protein G for industrial purification of IgG/HSA. Moreover, development of predictable and efficient systems for protein labeling is another focus of her research group. She is also part of the executive management team within the Human Protein Atlas project, Stockholm, Sweden, where she is Director of Protein Science.
is Professor of Cell Biology at the Medical Faculty of the University of Occidental Brittany in Brest, France, since 2006. He also leads a research group (in INSERM U613 headed by Prof. Claude Ferec) focussed on the use of budding yeast Saccharomyces cerevisiae to model human diseases. After a PhD in the Cell Cycle Lab of Dr. Carl Mann, SBGM, Gif sur Yvette in France, he held a postdoctoral position for four years at the Swiss Institute of Cancer Research in the Cell Cycle team of Prof. Matthias Peter. After which he was appointed as a CNRS Research Investigator in the Amyloids and Cell Division Cycle Group headed by Dr. Laurent Meijer in Roscoff, until 2006. He completed his HDR (“Habilitation � Diriger des Recherches”) in 2004 at the University of Occidental Brittany. He has published numerous papers in major journals and holds five patents. Areas of expertise: drug screening, cell cycle/cancer, prion-based diseases, neurodegenerative diseases, mitochondrial diseases and budding yeast.
is the Lawrence R. Quarles Professor of Chemical Engineering at the University of Virginia, USA. He received his PhD in Chemical Engineering from the University of Delaware in 1984. His research interests are in bioseparations with emphasis on protein adsorption, ion exchange, and chromatography. Giorgio is a consultant for chemical, pharmaceutical, and process chromatography companies. He has authored more than 120 journal articles, is the holder of two US patents, and is a co-author of Section 16 – Adsorption and Ion Exchange of Perry's Chemical Engineers' Handbook and of a book titled “Protein Chromatography – Process Development and Scale-up”. He has served on the Scientific Advisory Committee of the 5th, 8th, and 10th International Conference on Fundamentals of Adsorption (FOA5, FOA8, FOA10), as Vice-Chair of FOA9, and as Chair of the International Symposium, Exhibit and Workshops on Preparative Chromatography (PREP) in 2009 and 2011.
is Pegasus Professor and University Board of Trustee Chair at the University of Central Florida (UCF, FL, USA). Henry is recognized for his pioneering inventions on chloroplast genetic engineering. He used this concept to confer plant traits, including herbicide, insect, disease resistance, drought/salt tolerance and phytoremediation. Furthermore, this concept has been used in his laboratory to express several therapeutic proteins, including vaccine antigens and biopharmaceuticals. He is an elected Fellow of the American Association for the Advancement of Science and is an elected member of the Italian Academy of Sciences. Henry is the technical founder of several biotech companies and an inventor on more than 95 patents in the US and abroad. He has published over 200 articles in scientific journals, 30 awarded patents and is cited over 3500 times. Henry's laboratory is a global leader in genomics and has determined the complete chloroplast genome sequences of more than twenty crop plants. His research has been featured on the cover of several high impact scientific journals, ranked by Nature Biotechnology among the top ten inventions of this decade and among Biomed Central's Hot 100 authors in the world. He has served as a consultant to the United Nations, several National Institutes of Health or National Academy of Science panels in the USA. His research has been featured often in the press including Discovery Channel, Voice of America, CNN, BBC, New York Times and Scientific American.
is currently Associate Professor of Chemical Engineering and Bioengineering at Ecole Polytechnique Federale de Lausanne (EPFL), in Lausanne, Switzerland. Vassily received his MS and PhD in Chemical Engineering from the California Institute of Technology, and his Diploma in Chemical Engineering from the University of Patras, in Greece. After the completion of his doctoral studies, he held a research group leader position at the Swiss Federal Institute of Technology in Zurich (ETHZ), Switzerland. Prior to joining EPFL, Vassily worked for three years in DuPont, Cargill, and Cargill Dow, and he has been Assistant Professor at Northwestern University, at Illinois, USA. Vassily's research interests are in the areas of computational systems biology, biotechnology, and complexity. In addition to Biotechnology Journal, Vassily is Associate Editor of the journals Biotechnology & Bioengineering and Metabolic Engineering, and he serves on the editorial advisory board of the journals Bioprocess and Biosystems Engineering, Journal of Chemical Technology and Biotechnology, and Industrial Biotechnology. He has written over 60 technical publications and he is co-inventor in three patents and patent applications. Vassily is a Fellow of the American Institute for Medical and Biological Engineering, he was a DuPont Young Professor, and he has also received the Jay Bailey Young Investigator Award in Metabolic Engineering.
Luke P. Lee
is Arnold and Barbara Silverman Distinguished Professor at UC Berkeley, USA, where he is affiliated with Department of Bioengineering, Institute of Quantitative Biomedical Research, and Biophysics graduate program. He is also Director of Biomedical Institute for Global Healthcare Research & Technology (BIGHEART) and Co-Director of Berkeley Sensor & Actuator Center. He was Chair Professor in Systems Nanobiology at the Swiss Federal Institute of Technology (ETH, Zurich). He received both his BA in Biophysics and PhD in Applied Physics (major) & Bioengineering (minor) from UC Berkeley. His current research interests are bionanoscience, molecular imaging of living cells, cell reprogramming, global health diagnostics, preventive personalized medicine, biotechnology, and Biologically-inspired Photonics-Optofluidics-Electronics Technology and Science (BioPOETS). Luke has authored and co-authored over 250 papers and 33 patents. He is a Fellow of the Royal Society of Chemistry.
is Professor of Biotechnology at Graz University of Technology, Austria where he currently serves as Head of the Institute of Biotechnology and Biochemical Engineering. His main research interests are applied enzymology and biocatalytic reaction engineering, especially in the fields of carbohydrate transformations, renewable resource utilization, and fine chemical synthesis. Bernd has authored more than 150 papers in peer-reviewed journals and is inventor in patents that have led to biocatalytic process development at the industrial scale. He is actively involved in collaborative research with industrial partners, mainly within the Austrian Center of Industrial Biotechnology (ACIB GmbH) and the Research Center of Pharmaceutical Engineering (RCPE GmbH).
earned his PhD in Chemistry, Kinetics and Catalysis from the School of Chemistry, Lomonosov State University, Moscow, Russia and DSc. (= Dr. habil.) in Biochemistry from the A. N. Bach Institute of Biochemistry, Russian Academy of Sciences. After a short scientific fellowship at the Leipzig Institute of Biotechnology in 1988-1989, he became Head of the Division of Bioconversion of Renewable Resources at the Bach Institute of Biochemistry. In 1992, after establishment of the Department of Ecology in the Russian University of Peoples Friendship, Moscow, he was invited to the position of Professor in Environmental Biotechnology at this University. In 1997 he was also appointed Head of the Department of Environmental Biotechnology at the Bach Institute of Biochemistry, Moscow and in 2000 earned the degree of Professor in Biotechnology from the State Attestation Committee of Russian Federation. Since then he is a member of scientific councils of a number of Russian institutes. Since the end of the 90s he also participated in collaborative projects with leading European biotechnology laboratories within the framework of FP4 and FP7. Mikhail has authored more than 150 research articles and reviews in peer-reviewed journals, book chapters, Russian patents and books. He currently serves on the editorial boards of several biotechnological journals, the Pool of Experts of the European Science Foundation and consultant of various biotech companies. His field of expertise includes chemical enzymology, plant biopolymers, biofuels, fungal degradation of xenobiotics and nanobiotechnology.
studied Biology and Chemistry in Bonn and Braunschweig, Germany. After post-doctoral work in Cologne and Munich as a Heisenberg Fellow he took up a professorship at the University of Mainz, Germany. Since 1989 Michael has been Professor of Pharmaceutical Biology at the University of Heidelberg and was appointed Director of the Institute of Pharmacy and Molecular Biotechnology (IPMB) in 2002. Michael served as Dean or Vice Dean of the Faculty of Pharmacy from 1990–2002. In 2001 he became Founding Dean of the bachelor/master course in Molecular Biotechnology at the University of Heidelberg; he remained Student Dean until 2005 and will take another term of office starting January 2012. From 2005–2007 he was Dean of Research at the Faculty of Life Sciences. Since 2004 he is Guest Professor at the North-East Forestry University Harbin (China). Since 2011 he is Adjunct Professor of Southern Cross University (Lismore, Australia). His scientific interests focus on bioactive natural products, pharmacology and toxicology of natural products, chemical ecology, molecular ecology and molecular evolution. He is the author of numerous scientific papers and books on biotechnology, medicinal plants and evolution.
is currently Professor of Chemical Engineering at the Technical University of Denmark (DTU, Lyngby), a position he took up in 2007 after 20 years at University College London (UCL, London, UK). He leads a collaborative research team working on the scale-up and implementation of process technology suitable for new biocatalytic and chemo-enzymatic processes involving pilot-scale and laboratory experimental evaluation, process modeling and flow-sheeting. He has published 120 papers and around 180 conference presentations. He has wide industrial experience from ICI and international consultancy and sits on a number of scientific advisory boards. In addition to Biotechnology Journal, he is an Associate Editor for Biocatalysis and Biotransformation and serves on a number of other journal editorial boards. He is a Fellow of the Institution of Chemical Engineers (UK) and a Fellow of the Royal Academy of Engineering (UK).